Caseware UK (AP4) 2023.0.135 2023.0.135 2023-04-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.No description of principal activity22truetruefalse 05540339 2023-04-01 2024-03-31 05540339 2022-04-01 2023-03-31 05540339 2024-03-31 05540339 2023-03-31 05540339 c:CompanySecretary1 2023-04-01 2024-03-31 05540339 c:Director1 2023-04-01 2024-03-31 05540339 c:Director2 2023-04-01 2024-03-31 05540339 c:RegisteredOffice 2023-04-01 2024-03-31 05540339 d:OfficeEquipment 2023-04-01 2024-03-31 05540339 d:OfficeEquipment 2024-03-31 05540339 d:OfficeEquipment 2023-03-31 05540339 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 05540339 d:CurrentFinancialInstruments 2024-03-31 05540339 d:CurrentFinancialInstruments 2023-03-31 05540339 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 05540339 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 05540339 d:ShareCapital 2024-03-31 05540339 d:ShareCapital 2023-03-31 05540339 d:RetainedEarningsAccumulatedLosses 2024-03-31 05540339 d:RetainedEarningsAccumulatedLosses 2023-03-31 05540339 c:OrdinaryShareClass1 2023-04-01 2024-03-31 05540339 c:OrdinaryShareClass1 2024-03-31 05540339 c:OrdinaryShareClass1 2023-03-31 05540339 c:FRS102 2023-04-01 2024-03-31 05540339 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 05540339 c:AbridgedAccounts 2023-04-01 2024-03-31 05540339 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05540339 2 2023-04-01 2024-03-31 05540339 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 05540339










VASCULAR CONSULTING LIMITED

Unaudited
Financial statements
Information for filing with the registrar
For the year ended 31 March 2024

 
VASCULAR CONSULTING LIMITED
 

Company Information


Directors
Prof. P A Gaines 
Mrs E J Gaines 




Company secretary
Mrs E J Gaines



Registered number
05540339



Registered office
Cannon Hall
Butts Hill

Sheffield

South Yorkshire

S17 4AN





 
VASCULAR CONSULTING LIMITED
Registered number: 05540339

Balance sheet
As at 31 March 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
3,466
3,399

  
3,466
3,399

Current assets
  

Debtors
 5 
20,849
15,090

Cash at bank and in hand
  
1,425,171
1,358,046

  
1,446,020
1,373,136

Creditors: amounts falling due within one year
 6 
(70,353)
(52,375)

Net current assets
  
 
 
1,375,667
 
 
1,320,761

Net assets
  
1,379,133
1,324,160


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
1,379,033
1,324,060

  
1,379,133
1,324,160


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 August 2024.






Prof. P A Gaines
Director

The notes on pages 2 to 5 form part of these financial statements.
Page 1

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2024

1.


General information

Vascular Consulting Limited is a private company limited by shares incorporated in England within the United Kingdom. The address of the registered office is given in the company information page of these financial statements.
The financial statements are presented in sterling which is the functional currency of the company.
The significant accounting policies applied in the preparation of of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates and value added tax.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 2

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2024

2.Accounting policies (continued)

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors , during the year was 2 (2023 - 2).

Page 3

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2024

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2023
8,319


Additions
1,851



At 31 March 2024

10,170



Depreciation


At 1 April 2023
4,920


Charge for the year on owned assets
1,784



At 31 March 2024

6,704



Net book value



At 31 March 2024
3,466



At 31 March 2023
3,399


5.


Debtors

2024
2023
£
£


Trade debtors
8,250
10,870

Other debtors
12,599
-

Amounts recoverable
-
4,220

20,849
15,090



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Taxation and social security
55,527
39,064

Other creditors
11,646
10,241

Accruals and deferred income
3,180
3,070

70,353
52,375


Page 4

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2024

7.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 -100) Ordinary shares of £1.00 each
100
100



Page 5